...
首页> 外文期刊>Journal of Clinical Oncology >Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment.
【24h】

Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment.

机译:保乳治疗后早期乳腺癌患者的晚期心源性死亡率和发病率。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Several studies have reported increased cardiac mortality related to the use of left-sided breast or chest-wall irradiation. This study was undertaken as a comprehensive examination of the long-term cardiac mortality and morbidity after breast irradiation using contemporary irradiation techniques. METHODS: The medical records of 961 consecutive patients presenting between 1977 and 1994 with stage I or II breast cancer treated with breast conservation treatment were reviewed. Data was recorded on baseline pretreatment patient, tumor and treatment characteristics and on subsequent cancer or cardiac related events. The median follow-up time was 12 years. RESULTS: There was no difference in overall mortality from any cardiac cause (P = .25). Death from any cardiac cause occurred in 2% of right-sided patients and 3.5% of left-sided patients. However, in the second decade after treatment, there was a higher rate of cardiac deaths in left-sided patients, with a cumulative risk of 6.4% (95% CI, 3.5% to 11.5%) for left-sided compared with 3.6% (95% CI, 1.8% to 7.2%) for right-sided patients at 20 years. There were statistically higher rates of chest pain, coronary artery disease, and myocardial infarction diagnosed in left-sided patients (all P < or = .002). The presence of hypertension was associated with a higher risk of coronary artery disease in left-sided patients. CONCLUSION: Irradiation to the left breast is not associated with a higher risk of cardiac death up to 20 years after treatment, but is associated with an increased rate of diagnoses of coronary artery disease and myocardial infarction compared with right breast treatment.
机译:目的:一些研究报告了与使用左侧乳房或胸壁照射有关的心脏死亡率增加。这项研究是对使用现代放射技术进行乳房照射后长期心脏死亡率和发病率的综合检查。方法:回顾性分析了1977年至1994年间接受保乳治疗的连续961例I或II期乳腺癌患者的病历。记录有关基线治疗前患者,肿瘤和治疗特征以及随后的癌症或心脏相关事件的数据。中位随访时间为12年。结果:任何心脏原因的总死亡率均无差异(P = .25)。 2%的右侧患者和3.5%的左侧患者因任何心脏原因死亡。然而,在治疗后的第二个十年中,左侧患者的心源性死亡发生率更高,左侧患者的累积风险为6.4%(95%CI,3.5%至11.5%),而3.6%(右侧患者在20岁时为95%CI(1.8%至7.2%)。在左侧患者中,诊断出的胸痛,冠状动脉疾病和心肌梗塞的发生率在统计学上较高(所有P <或= .002)。高血压的存在与左侧患者冠状动脉疾病的较高风险相关。结论:在治疗后长达20年的时间里,对左乳房进行放射治疗不会导致更高的心源性死亡风险,但与右乳房处理相比,与冠状动脉疾病和心肌梗死的诊断率增加相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号